FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NASDAQ:GERN

Sort
E.g., 2013-05-18
E.g., 2013-05-18
Enter a comma separated list of user names.

Strange Volume of Geron Corporation - NASDAQ:GERN

Posted by akki on November 16th, 2011

Geron Corporation (NASDAQ:GERN) witnessed volume of 9.87 million shares during last trade however it holds an average trading capacity of 1.28 million shares. GERN last trade opened at $1.75 reached intraday low of $1.60 and went -20.45% down to close at $1.75.

Read Full Article and Disclaimer at:http://stockblizzard.com/7458/business-news/strange-volume-of-geron-corp...

Geron Corporation (Nasdaq:GERN) announced that management will present a company overview upcoming investor conference; UBS Global Life Sciences Conference in New York City. Hoyoung Huh, M.D., Ph.D., Geron's Executive Chairman, and Stephen M. Kelsey, M.D., Executive Vice President, Head of Research & Development and Chief Medical Officer will present at 10:30 a.m.

Geron Corporation (NASDAQ:GERN) previously announced the publication of preclinical data demonstrating that the company’s telomerase inhibitor drug, imetelstat (GRN163L), currently in Phase 2 clinical trials, targets cancer stem cells from multiple myeloma, pancreatic and breast cancers.

ADVERTISE WITH US